Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia

BACKGROUND: Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hoffmann, Falk, van den Bussche, Hendrik, Wiese, Birgitt, Schön, Gerhard, Koller, Daniela, Eisele, Marion, Glaeske, Gerd, Scherer, Martin, Kaduszkiewicz, Hanna
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3262154/
https://ncbi.nlm.nih.gov/pubmed/22145796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-11-190
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi